ZERIT (STAVUDINE) — FDA Approval NDA020412 (BRISTOL)
ZERIT (STAVUDINE) — FDA Approval NDA020412 (BRISTOL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ZERIT; Active ingredients: STAVUDINE; Application number: NDA020412.
| Brand name | ZERIT |
|---|---|
| Active ingredients | STAVUDINE |
| Application number | NDA020412 |
| Sponsor | BRISTOL |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 5 |
| First approval date | 19940624 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →